JP2015509950A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015509950A5 JP2015509950A5 JP2014559248A JP2014559248A JP2015509950A5 JP 2015509950 A5 JP2015509950 A5 JP 2015509950A5 JP 2014559248 A JP2014559248 A JP 2014559248A JP 2014559248 A JP2014559248 A JP 2014559248A JP 2015509950 A5 JP2015509950 A5 JP 2015509950A5
- Authority
- JP
- Japan
- Prior art keywords
- oligopeptide
- acylated peptide
- terminal acylated
- peptide
- terminal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 15
- 108010038807 Oligopeptides Proteins 0.000 claims 14
- 102000015636 Oligopeptides Human genes 0.000 claims 14
- 150000001413 amino acids Chemical class 0.000 claims 3
- -1 aromatic amino acid Chemical class 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims 2
- 229930195729 fatty acid Natural products 0.000 claims 2
- 239000000194 fatty acid Substances 0.000 claims 2
- 150000004665 fatty acids Chemical group 0.000 claims 2
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 239000008203 oral pharmaceutical composition Substances 0.000 claims 2
- 102000004400 Aminopeptidases Human genes 0.000 claims 1
- 108090000915 Aminopeptidases Proteins 0.000 claims 1
- 102000005367 Carboxypeptidases Human genes 0.000 claims 1
- 108010006303 Carboxypeptidases Proteins 0.000 claims 1
- 108090000317 Chymotrypsin Proteins 0.000 claims 1
- 108010067372 Pancreatic elastase Proteins 0.000 claims 1
- 102000016387 Pancreatic elastase Human genes 0.000 claims 1
- 108090000631 Trypsin Proteins 0.000 claims 1
- 102000004142 Trypsin Human genes 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 229960002376 chymotrypsin Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 230000017854 proteolysis Effects 0.000 claims 1
- 230000002797 proteolythic effect Effects 0.000 claims 1
- 239000012588 trypsin Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12157616.9 | 2012-03-01 | ||
| EP12157616 | 2012-03-01 | ||
| US201261625896P | 2012-04-18 | 2012-04-18 | |
| US61/625,896 | 2012-04-18 | ||
| PCT/EP2013/054177 WO2013128003A1 (en) | 2012-03-01 | 2013-03-01 | N-terminally modified oligopeptides and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015509950A JP2015509950A (ja) | 2015-04-02 |
| JP2015509950A5 true JP2015509950A5 (https=) | 2016-04-21 |
| JP6382111B2 JP6382111B2 (ja) | 2018-08-29 |
Family
ID=49081680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014559248A Expired - Fee Related JP6382111B2 (ja) | 2012-03-01 | 2013-03-01 | Ｎ末端改変オリゴペプチド及びその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20150038435A1 (https=) |
| EP (1) | EP2820150A1 (https=) |
| JP (1) | JP6382111B2 (https=) |
| CN (1) | CN104136626B (https=) |
| WO (1) | WO2013128003A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY36870A (es) * | 2015-08-28 | 2017-03-31 | Hanmi Pharm Ind Co Ltd | Análogos de insulina novedosos |
| US11021514B2 (en) | 2016-06-01 | 2021-06-01 | Athira Pharma, Inc. | Compounds |
| JP7158378B2 (ja) | 2016-09-23 | 2022-10-21 | ハンミ ファーマシューティカル カンパニー リミテッド | インスリン受容体との結合力が減少された、インスリンアナログ及びその用途 |
| JP2020506237A (ja) * | 2017-02-06 | 2020-02-27 | アリゼ・ファルマ・トロワ・エスアエス | 骨障害の改善のための化合物、組成物、及びその使用 |
| KR102629006B1 (ko) | 2017-03-23 | 2024-01-25 | 한미약품 주식회사 | 인슐린 수용체와의 결합력이 감소된 인슐린 아날로그의 결합체 및 이의 용도 |
| EP3728304B1 (en) * | 2017-12-21 | 2025-02-12 | Bachem Holding AG | Solid phase synthesis of acylated peptides |
| WO2019161487A1 (en) * | 2018-02-20 | 2019-08-29 | University Of Manitoba | Food protein-derived peptides as bitter taste blockers |
| US11192932B2 (en) * | 2018-05-24 | 2021-12-07 | Amolyt Pharma | Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders |
| JP7273073B2 (ja) * | 2018-07-06 | 2023-05-12 | エニジェン カンパニー．，リミテッド． | ペプチド複合体を有効成分として含有する微細ホコリ除去または吸着用化粧料組成物 |
| KR102507392B1 (ko) * | 2020-06-18 | 2023-03-08 | 애니젠 주식회사 | 유기산-올리고펩타이드 복합체를 유효성분으로 포함하는 피부 노화 및 주름 개선용 조성물 |
| JP2023542867A (ja) | 2020-09-11 | 2023-10-12 | グリンプス バイオ， インコーポレイテッド | 疾患の検出／診断、病期分類、モニタリング及び処置のための生体外でのプロテアーゼ活性検出 |
| CA3204051A1 (en) | 2021-01-20 | 2022-07-28 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| JP7642830B2 (ja) | 2021-09-15 | 2025-03-10 | バイキング・セラピューティクス・インコーポレイテッド | 代謝及び肝臓障害の処置のための組成物及び方法 |
| WO2023172648A2 (en) * | 2022-03-09 | 2023-09-14 | Glympse Bio, Inc. | Fluorogenic substrates for aminopeptidase detection in biofluids |
| CN119325466A (zh) * | 2022-04-08 | 2025-01-17 | 尚威天成信使核糖核酸治疗公司 | 可电离脂质化合物和脂质纳米颗粒组合物 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05213990A (ja) * | 1991-02-27 | 1993-08-24 | Taisho Pharmaceut Co Ltd | トリペプチド誘導体 |
| US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| GB9409496D0 (en) * | 1994-05-12 | 1994-06-29 | London Health Ass | Method for improving glycaemic control in diabetes |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| WO2000018895A1 (en) * | 1998-09-25 | 2000-04-06 | The Children's Medical Center Corporation | Short peptides which selectively modulate the activity of protein kinases |
| FR2864085B1 (fr) * | 2003-12-18 | 2010-09-17 | Centre Nat Rech Scient | Nouveaux modulateurs du proteasome |
| US20070292354A1 (en) * | 2004-09-23 | 2007-12-20 | Guerbet | Contrast Agents Encapsulating Systems for Cest Imaging |
| AU2006212922B2 (en) * | 2005-02-09 | 2011-04-21 | Helix Biomedix Inc. | Antimicrobial hexapeptides |
| DE102006047529A1 (de) * | 2006-10-07 | 2008-04-10 | Evonik Goldschmidt Gmbh | Oligopeptide enthaltende dermatologische Zusammensetzungen zur Steigerung der Hautempfindlichkeit und der neuronalen Reizwahrnehmung |
| CA2989778C (en) * | 2007-01-19 | 2020-06-30 | Kai Pharmaceuticals, Inc. | Method of modifying peptide compositions |
| WO2008128038A2 (en) * | 2007-04-13 | 2008-10-23 | The Scripps Research Institute | Methods and compositions for treating cardiac dysfunctions |
| US20110144010A1 (en) | 2007-06-01 | 2011-06-16 | Novo Nordisk A/S | Spontaneously Dispersible Preconcentrates Including a Peptide Drug in a Solid or Semisolid Carrier |
| EP2190872B1 (en) | 2007-09-05 | 2018-03-14 | Novo Nordisk A/S | Glucagon-like peptide-1 derivatives and their pharmaceutical use |
| ES2342754B1 (es) * | 2008-10-03 | 2011-05-11 | Lipotec, S.A. | Peptidos utiles en el tratamiento y/o cuidado de la piel, mucosas, cuero cabelludo y/o cabello y su uso en composiciones cosmeticas o farmaceuticas. |
| EP2370059A1 (en) | 2008-11-28 | 2011-10-05 | Novo Nordisk A/S | Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides |
| CA2786953A1 (en) | 2010-01-12 | 2011-07-21 | Florian Anders Foeger | Pharmaceutical compositions for oral administration of insulin peptides |
| WO2012026743A2 (ko) * | 2010-08-23 | 2012-03-01 | 포항공과대학교 산학협력단 | 라벨링제 및 이를 이용한 아미노산 서열 및 단백질 다중 정량 동시 분석방법 |
| CN102219850A (zh) * | 2011-05-03 | 2011-10-19 | 上海格尼生物技术有限公司 | 新的长效glp-1化合物 |
| CN102311483A (zh) * | 2011-07-13 | 2012-01-11 | 大连伊美生物科技有限公司 | 一种低溶血性抗菌脂肽及其制备方法 |
-
2013
- 2013-03-01 US US14/380,914 patent/US20150038435A1/en not_active Abandoned
- 2013-03-01 CN CN201380011936.8A patent/CN104136626B/zh not_active Expired - Fee Related
- 2013-03-01 WO PCT/EP2013/054177 patent/WO2013128003A1/en not_active Ceased
- 2013-03-01 EP EP13707004.1A patent/EP2820150A1/en not_active Withdrawn
- 2013-03-01 JP JP2014559248A patent/JP6382111B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015509950A5 (https=) | ||
| Kimura et al. | KMI-358 and KMI-370, highly potent and small-sized BACE1 inhibitors containing phenylnorstatine | |
| JP2019533722A5 (https=) | ||
| ES2449615T3 (es) | Péptidos y su uso | |
| JP5378998B2 (ja) | 炎症性メディエーターの放出を減弱させるための方法及びそれにおいて有用なペプチド | |
| NO20071369L (no) | Antimikrobiske peptider omfattende et arginin- og/eller lysin-inneholdende motiv | |
| WO2009011544A3 (en) | Insulinotropic peptide derivative wherein its n-terminal amino acid is modified | |
| HRP20140616T1 (hr) | Peptidni analog oksintomodulina | |
| CN103476792B (zh) | 人乳铁蛋白衍生肽及其用途 | |
| JP2012506442A5 (https=) | ||
| HRP20171048T1 (hr) | Novi agonisti angiotenzinskog receptora tipa 2 (at2) i njihove upotrebe | |
| JP2010512326A5 (https=) | ||
| WO2007061829A3 (en) | Pharmaceutical composition | |
| ES2387435B1 (es) | Uso de heptapéptidos para el control de la hipertensión | |
| JP2019534247A5 (https=) | ||
| AU2003264679A8 (en) | Peptides having antimicrobial properties and compositions containing same in particular for preserving foods | |
| Rall et al. | Boswellic acids and protease activities | |
| JP2021531246A5 (https=) | ||
| BR112012012190A2 (pt) | peptídeo, método e kit de diagnóstico e composição farmacêutica | |
| JP2015533821A5 (https=) | ||
| JP2013529600A5 (https=) | ||
| Bose et al. | Camostat in COVID-19 | |
| ES2321358B1 (es) | Uso de peptidos derivados de la lactoferrina para preparar formulaciones inhibidoras de la enzima conversora de angiotensina i. | |
| ES2320057B1 (es) | Uso de exapeptidos para preparar formulaciones inhibidoras de la enzima conversora de angiotensina i. | |
| JP2008007448A5 (https=) |